SKERLJ RENATO (Chief Scientific Officer) sold 12.2% of their position (5.83K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $47.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/10/2020ACC: 0001628280-20-013423
Officer· Chief Scientific Officer
Since Jun 2020
-5.83K
Net shares
Net seller
$47.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.83K
Price / share
$8.05
Trade value
$46.96K
% of position
12.2%
9/9/2020
47.91K→42.08K
Total
Net shares
−5.83K
Net value
-$46.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2020 | S · Sale | −5.83K | $8.05 | $46.96K | 12.2% | 47.91K | 42.08K |
| Total | −5.83K | -$46.96K | ||||||
Derivative Transactions0
No derivative transactions reported